The Trump Administration’s plan to allocate $2 billion in grants to nine quantum computing companies, including D-Wave Quantum (NYSE: QBTS), has sparked significant market activity. Following the Wall Street Journal’s report, D-Wave shares surged by 66% over three days, reflecting heightened investor interest. The U.S. Department of Commerce confirmed the grants, which are part of the CHIPS and Science Act, aimed at bolstering the quantum ecosystem for national security and technological leadership.
This funding will see D-Wave and six other firms receiving $100 million each, while larger players like IBM and Globalfoundries will secure $1 billion and $375 million, respectively. However, despite the substantial capital injection, D-Wave’s financial health raises concerns, as the company has burned through over $100 million in the past year. The grants may extend its runway, but with no profits expected in the near term, investors must weigh the risks carefully.
For market professionals, the key takeaway is to assess whether the short-term gains in D-Wave’s stock price justify the long-term uncertainties surrounding its profitability and operational viability.
Source: fool.com